Shanghai Hile Bio-Technology Co (SHSE:603718) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co Change In Receivables?

Shanghai Hile Bio-Technology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Shanghai Hile Bio-Technology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shanghai Hile Bio-Technology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥54.9 Mil. It means Shanghai Hile Bio-Technology Co's Accounts Receivable declined by ¥54.9 Mil from Dec. 2022 to Dec. 2023 .

Shanghai Hile Bio-Technology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥96.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai Hile Bio-Technology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 125.34.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai Hile Bio-Technology Co's liquidation value for the three months ended in Mar. 2024 was ¥-7.0 Mil.

Shanghai Hile Bio-Technology Co Change In Receivables Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co Change In Receivables Chart

Shanghai Hile Bio-Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-24.12

11.71

-68.69

24.66

54.93

Shanghai Hile Bio-Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Hile Bio-Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Shanghai Hile Bio-Technology Co (SHSE:603718) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai Hile Bio-Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	96.565	/	70.304	*	91
=	125.34

2. In Ben Graham's calculation of liquidation value, Shanghai Hile Bio-Technology Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai Hile Bio-Technology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	338.466	-	464.46	+	0.75 * 96.565	+	0.5 * 93.045
=	-7.0

Shanghai Hile Bio-Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Hile Bio-Technology Co (SHSE:603718) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shanghai Jinhai Road 6720, Shanghai, CHN, 201403

Website

http://www.hile-bio.com

Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.

Executives

Zhang Lu	Director
Liu Han Ping	Directors, senior managers
Zhou Yu Sheng	Supervisors
Zhang Hai Ming	Director
Sun Guo Bao	Supervisors
Zhang Yue	Director
Su Bin	Director
Wu Ling Yue	senior management

Shanghai Hile Bio-Technology Co (SHSE:603718) Headlines

No Headlines